Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1799-1808, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (61)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liao, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liao, J. K.
Related Collections
Right arrow Arnold O. Beckman Conference
Right arrow Proteomics and Protein Markers
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1998;44:1799-1808.)
© 1998 American Association for Clinical Chemistry, Inc.

Proceedings of the 21st Arnold O. Beckman Conference

Endothelium and acute coronary syndromes

James K. Liao

Abstract

The vascular endothelium is a dynamic endocrine organ that regulates contractile, secretory, and mitogenic activities in the vessel wall and hemostatic processes within the vascular lumen. Risk factors for atherosclerosis such as cigarette smoking, hypertension, and increased serum lipid concentrations impair endothelial function and lead to the development of atherosclerotic vessels, which cause acute coronary syndromes. Atherosclerotic vessels progress from scattered foam cells to complex lesions with a lipid core and fibrous cap. Factors that weaken and cause the rupture of the fibrous cap will expose circulating blood products to the procoagulant materials in the lipid core. Thrombosis and subsequent remodeling of the unstable plaque may be catastrophic or clinically silent depending on the degree of vascular occlusion and availability of collateral blood flow. Evidence is presented that supports the view that endothelial dysfunction is an early marker of atherosclerosis and an important contributor to the atherogenic process.




The following articles in journals at HighWire Press have cited this article:


Home page
 J CARDIOVASC PHARMACOL THERHome page
R. Siekmeier, T. Grammer, and W. Marz
Roles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2008; 13(4): 279 - 297.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
M. J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland
Microparticles in cardiovascular diseases
Cardiovasc Res, August 1, 2003; 59(2): 277 - 287.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
K. Gertz, U. Laufs, U. Lindauer, G. Nickenig, M. Bohm, U. Dirnagl, and M. Endres
Withdrawal of Statin Treatment Abrogates Stroke Protection in Mice
Stroke, February 1, 2003; 34(2): 551 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Yang, L. Graham, S. Dikalov, R. P. Mason, J. R. Falck, J. K. Liao, and D. C. Zeldin
Overexpression of Cytochrome P450 CYP2J2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial Cells
Mol. Pharmacol., August 1, 2001; 60(2): 310 - 320.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
U. Laufs, M. Endres, F. Custodis, K. Gertz, G. Nickenig, J. K. Liao, and M. Bohm
Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription
Circulation, December 19, 2000; 102(25): 3104 - 3110.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. R. Bridges, F. H. Edwards, E. D. Peterson, and L. P. Coombs
The effect of race on coronary bypass operative mortality
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1870 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
U. Laufs, K. Gertz, P. Huang, G. Nickenig, M. Bohm, U. Dirnagl, M. Endres, and C. J. Vaughan
Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice Editorial Comment
Stroke, October 1, 2000; 31(10): 2442 - 2449.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.